相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modulating proteasome inhibitor tolerance in multiple myeloma: an alternative strategy to reverse inevitable resistance
Maolin Ge et al.
BRITISH JOURNAL OF CANCER (2021)
Exosomes mediate intercellular transfer of non-autonomous tolerance to proteasome inhibitors in mixed-lineage leukemia
Maolin Ge et al.
CANCER SCIENCE (2020)
Restoring MLL reactivates latent tumor suppression-mediated vulnerability to proteasome inhibitors
Maolin Ge et al.
ONCOGENE (2020)
Evolution of Resistance in Cancer: A Cell Cycle Perspective
Kagan Dokumcu et al.
FRONTIERS IN ONCOLOGY (2019)
Diminished interaction between mutant NOTCH1 and the NuRD corepressor complex upregulates CCL17 in chronic lymphocytic leukemia
Shifen Wang et al.
LEUKEMIA (2019)
Cancer Cell Derived Small Extracellular Vesicles Contribute to Recipient Cell Metastasis Through Promoting HGF/c-Met Pathway
Zhi Qiao et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors
Yuetong Wang et al.
CELL REPORTS (2019)
Targeting Cancer Cell Dormancy
Ariadna Recasens et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
Charissa Kim et al.
CELL (2018)
Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer
Soon-Ki Hong et al.
MOLECULAR CANCER (2018)
The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer
Ravi Salgia et al.
TRENDS IN CANCER (2018)
HERP Binds TBK1 To Activate Innate Immunity and Repress Virus Replication in Response to Endoplasmic Reticulum Stress
Maolin Ge et al.
JOURNAL OF IMMUNOLOGY (2017)
Rare cell variability and drug- induced reprogramming as a mode of cancer drug resistance
Sydney M. Shaffer et al.
NATURE (2017)
Proteasome inhibitors in cancer therapy
Elisabet E. Manasanch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Epigenetic plasticity and the hallmarks of cancer
William A. Flavahan et al.
SCIENCE (2017)
Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations
Michelle Vaz et al.
CANCER CELL (2017)
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance
Brian B. Liau et al.
CELL STEM CELL (2017)
Molecular mechanisms of drug resistance and its reversal in cancer
Melis Kartal-Yandim et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2016)
Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling
Xing-Ding Zhang et al.
CANCER CELL (2016)
Autophagy maintains stemness by preventing senescence
Laura Garcia-Prat et al.
NATURE (2016)
Distinguishing between resistance, tolerance and persistence to antibiotic treatment
Asher Brauner et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Hijacked in cancer: the KMT2 (MLL) family of methyltransferases
Rajesh C. Rao et al.
NATURE REVIEWS CANCER (2015)
Proteasome Inhibitors Evoke Latent Tumor Suppression Programs in Pro-B MLL Leukemias through MLL-AF4
Han Liu et al.
CANCER CELL (2014)
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
Birgit Knoechel et al.
NATURE GENETICS (2014)
Single-cell analyses of transcriptional heterogeneity during drug tolerance transition in cancer cells by RNA sequencing
Mei-Chong Wendy Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Poised epigenetic states and acquired drug resistance in cancer
Robert Brown et al.
NATURE REVIEWS CANCER (2014)
Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
Chungyee Leung-Hagesteijn et al.
CANCER CELL (2013)
Cdks, cyclins and CKIs: roles beyond cell cycle regulation
Shuhui Lim et al.
DEVELOPMENT (2013)
ASH2L Regulates Ubiquitylation Signaling to MLL: trans-Regulation of H3 K4 Methylation in Higher Eukaryotes
Lipeng Wu et al.
MOLECULAR CELL (2013)
The Pathogenesis of Mixed-Lineage Leukemia
Andrew G. Muntean et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Proteasome inhibitors in multiple myeloma: 10 years later
Philippe Moreau et al.
BLOOD (2012)
Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen
Sebastian Ochsenreither et al.
BLOOD (2012)
A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
Dharminder Chauhan et al.
CANCER CELL (2012)
Converting Cancer Therapies into Cures: Lessons from Infectious Diseases
Michael S. Glickman et al.
CELL (2012)
Estrogen-Dependent Gene Transcription in Human Breast Cancer Cells Relies upon Proteasome-Dependent Monoubiquitination of Histone H2B
Tanja Prenzel et al.
CANCER RESEARCH (2011)
Deubiquitinase Inhibition by Small-Molecule WP1130 Triggers Aggresome Formation and Tumor Cell Apoptosis
Vaibhav Kapuria et al.
CANCER RESEARCH (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia
Alex H. Beesley et al.
MOLECULAR CANCER (2010)
Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint
Han Liu et al.
NATURE (2010)
Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML
Yoriko Saito et al.
NATURE BIOTECHNOLOGY (2010)
Histone crosstalk between H2B monoubiquitination and H3 methylation mediated by COMPASS
Jung-Shin Lee et al.
CELL (2007)
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V. Krivtsov et al.
NATURE REVIEWS CANCER (2007)
Proteolysis of MLL family proteins is essential for Taspase1-orchestrated cell cycle progression
Shugaku Takeda et al.
GENES & DEVELOPMENT (2006)
Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia
C Holm et al.
LEUKEMIA RESEARCH (2006)
Targeting the cell cycle: A new approach to cancer therapy
GK Schwartz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Global histone modification patterns predict risk of prostate cancer recurrence
DB Seligson et al.
NATURE (2005)
Malignant hematopoietic cell lines:: in vitro models for the study of MLL gene alterations
HG Drexler et al.
LEUKEMIA (2004)
Cyclin A repression in quiescent cells is associated with chromatin remodeling of its promoter and requires Brahma/SN172α
M Coisy et al.
MOLECULAR CELL (2004)
Elevated levels of cyclin A1 and A (A2) mRNA in acute myeloid leukaemia are associated with increased survival
T Nakamaki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation
AS Weinmann et al.
METHODS (2002)
分享论文
